Literature DB >> 6604130

Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus.

H Mitsuya, L A Matis, M Megson, P A Bunn, C Murray, D L Mann, R C Gallo, S Broder.   

Abstract

Lymphocytes from a patient who had an unusually long survival after therapy for a human T cell leukemia/lymphoma virus (HTLV)-associated T cell lymphoma were stimulated in vitro with an autologous tumor cell line, and the generation of cytotoxic T lymphocytes (CTL) was studied. CTL generated were directed against autologous (HTLV-associated tumor cells. These propagated CTL were OKT3+, OKT4-, and OKT8+. The cytotoxic activity required target tumor cells that were infected with HTLV and also expressed histocompatibility antigens in common with the patient, suggesting a major histocompatibility complex-restricted associative recognition of target antigens expressed on the tumor cell membrane.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604130      PMCID: PMC2187097          DOI: 10.1084/jem.158.3.994

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2.

Authors:  K J Blank; H A Freedman; F Lilly
Journal:  Nature       Date:  1976-03-18       Impact factor: 49.962

Review 2.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

3.  Efficacy of cryopreserved spleen cells in murine tumor immunotherapy.

Authors:  A Fefer
Journal:  Transplantation       Date:  1972-04       Impact factor: 4.939

Review 4.  Possible immunological mechanisms in C-type viral leukemogenesis in mice.

Authors:  J N Ihle; J C Lee
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

5.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Retrovirus lymphomagenesis: relationship of normal immune receptors to malignant cell proliferation.

Authors:  I L Weissman; M S McGrath
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

7.  Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma.

Authors:  R C Gallo; D Mann; S Broder; F W Ruscetti; M Maeda; V S Kalyanaraman; M Robert-Guroff; M S Reitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.

Authors:  T J Eberlein; M Rosenstein; S A Rosenberg
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

  10 in total
  17 in total

1.  Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade.

Authors:  S Hanabuchi; T Ohashi; Y Koya; H Kato; F Takemura; K Hirokawa; T Yoshiki; H Yagita; K Okumura; M Kannagi
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Direct identification of tumor-associated peptide antigens.

Authors:  V H Engelhard
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Mitogenic stimulation of human tumor-infiltrating lymphocytes by secreted factor(s) from human tumor cell lines.

Authors:  B S Packard
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.

Authors:  S Koenig; P Earl; D Powell; G Pantaleo; S Merli; B Moss; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

Review 5.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 6.  Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

Authors:  M P Colombo; M Rodolfo
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

7.  Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Authors:  R Yarchoan; H G Guo; M Reitz; A Maluish; H Mitsuya; S Broder
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

8.  IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.

Authors:  Y Nakao; H Matsumoto; K Tsuji; T Miyazaki; T Masaoka; S Nakayama; K Kinoshita; T Shingami; T Matsui; T Fujita
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

9.  Deficient expression of class-I HLA in some cases of acute leukemia.

Authors:  W L Elkins; A Pickard; G R Pierson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I.

Authors:  H Uno; K Kawano; H Matsuoka; K Tsuda
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.